SI3204359T1 - Tetrahidroizokinolinski derivati - Google Patents
Tetrahidroizokinolinski derivatiInfo
- Publication number
- SI3204359T1 SI3204359T1 SI201531348T SI201531348T SI3204359T1 SI 3204359 T1 SI3204359 T1 SI 3204359T1 SI 201531348 T SI201531348 T SI 201531348T SI 201531348 T SI201531348 T SI 201531348T SI 3204359 T1 SI3204359 T1 SI 3204359T1
- Authority
- SI
- Slovenia
- Prior art keywords
- tetrahydroisoquinoline derivatives
- tetrahydroisoquinoline
- derivatives
- Prior art date
Links
- 125000003039 tetrahydroisoquinolinyl group Chemical class C1(NCCC2=CC=CC=C12)* 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/472—Non-condensed isoquinolines, e.g. papaverine
- A61K31/4725—Non-condensed isoquinolines, e.g. papaverine containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
- C07D217/06—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with the ring nitrogen atom acylated by carboxylic or carbonic acids, or with sulfur or nitrogen analogues thereof, e.g. carbamates
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Epidemiology (AREA)
- Addiction (AREA)
- Hospice & Palliative Care (AREA)
- Anesthesiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP14188174 | 2014-10-08 | ||
| EP15775688.3A EP3204359B1 (en) | 2014-10-08 | 2015-10-06 | Tetrahydroisoquinoline derivatives |
| PCT/EP2015/073053 WO2016055479A1 (en) | 2014-10-08 | 2015-10-06 | Tetrahydroisoquinoline derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SI3204359T1 true SI3204359T1 (sl) | 2020-10-30 |
Family
ID=51790569
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SI201531348T SI3204359T1 (sl) | 2014-10-08 | 2015-10-06 | Tetrahidroizokinolinski derivati |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US10105359B2 (OSRAM) |
| EP (1) | EP3204359B1 (OSRAM) |
| JP (1) | JP6622299B2 (OSRAM) |
| CN (1) | CN107001278B (OSRAM) |
| BR (1) | BR112017007123B1 (OSRAM) |
| CA (1) | CA2963951C (OSRAM) |
| CY (1) | CY1123417T1 (OSRAM) |
| DK (1) | DK3204359T3 (OSRAM) |
| EA (1) | EA035544B1 (OSRAM) |
| ES (1) | ES2821821T3 (OSRAM) |
| HR (1) | HRP20201469T1 (OSRAM) |
| HU (1) | HUE050664T2 (OSRAM) |
| LT (1) | LT3204359T (OSRAM) |
| PL (1) | PL3204359T3 (OSRAM) |
| PT (1) | PT3204359T (OSRAM) |
| RS (1) | RS60933B1 (OSRAM) |
| SI (1) | SI3204359T1 (OSRAM) |
| WO (1) | WO2016055479A1 (OSRAM) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MA43677A (fr) * | 2016-02-25 | 2018-11-28 | Asceneuron Sa | Inhibiteurs de glycosidases |
| EA036137B1 (ru) * | 2016-04-13 | 2020-10-02 | Юсб Байофарма Спрл | Производные тетрагидроизохинолина |
| CN107698433A (zh) * | 2017-09-12 | 2018-02-16 | 潍坊滨海石油化工有限公司 | 苯乙酸的制备方法 |
| ES2899679T3 (es) | 2017-12-01 | 2022-03-14 | UCB Biopharma SRL | Agentes de formación de imágenes |
| TWI725408B (zh) * | 2018-04-20 | 2021-04-21 | 美商美國禮來大藥廠 | 多巴胺d1受體正向異位調節劑 |
| SG11202112537YA (en) | 2019-07-01 | 2021-12-30 | UCB Biopharma SRL | A substituted tetrahydroisoquinoline derivative as a d1 positive allosteric modulator |
| MY210362A (en) | 2019-07-01 | 2025-09-13 | UCB Biopharma SRL | A substituted tetrahydroisoquinoline derivative as a d1 positive allosteric modulator |
| JP2023522980A (ja) * | 2020-04-24 | 2023-06-01 | ザ・リージエンツ・オブ・ザ・ユニバーシテイー・オブ・カリフオルニア | Ｎｕｒｒ１受容体調節因子及びその使用 |
| CN111943930B (zh) * | 2020-08-25 | 2022-11-01 | 南京三元阳普医药科技有限公司 | Lasmiditan的合成工艺 |
| PL4200280T3 (pl) * | 2020-10-07 | 2024-05-20 | Eli Lilly And Company | Pochodne fenylo-3,4-dihydroizochinolin-2(1h)-ylo-etan-1-onu jako dodatnie modulatory allosteryczne receptora dopaminy d1 |
| JP7756718B2 (ja) * | 2020-12-03 | 2025-10-20 | ユーシービー バイオファルマ エスアールエル | オクタヒドロイソキノリニル誘導体 |
| CN116615198A (zh) | 2020-12-18 | 2023-08-18 | Ucb生物制药有限责任公司 | 二氢异喹啉基衍生物 |
| KR20230121867A (ko) * | 2020-12-18 | 2023-08-21 | 유씨비 바이오파마 에스알엘 | 무정형 고체 분산체 |
| ES3004257T3 (en) * | 2020-12-18 | 2025-03-12 | UCB Biopharma SRL | Prodrugs of 2-(3,5-dichloro-1-methyl-indazol-4-yl)-1-[(1s,3r)-3-(hydroxymethyl)-5-(1-hydroxy-1-methyl-ethyl)-1-methyl-3,4-dihydro-1h-isoquinolin-2-yl]ethanone |
| IL303693A (en) * | 2020-12-18 | 2023-08-01 | UCB Biopharma SRL | Consequences of transformed tetrahydroisoquinoline as a positive D1 allosteric modulator |
| CA3211261A1 (en) | 2021-03-08 | 2022-09-15 | Kevin Michael BIGLAN | Use of mevidalen and other d1 positive allosteric modulators in the treatment of hallucinations and dementia-related psychosis |
| BR112023018196A2 (pt) | 2021-03-09 | 2023-12-12 | Lilly Co Eli | Uso de mevidalen e outros moduladores alostéricos positivos d1 para retardar a progressão da doença de parkinson |
| CN114671810B (zh) * | 2022-03-21 | 2024-03-22 | 济南鸿湾生物技术有限公司 | 一种咪唑苯脲的制备方法 |
| CN115611768B (zh) * | 2022-11-14 | 2024-03-05 | 郑州大学 | 一种3,4-二氯苯腈的合成方法 |
| CN118724764B (zh) * | 2024-06-07 | 2025-11-18 | 绍兴文理学院 | 一种芳基伯磺酰胺类化合物的制备方法 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4766131A (en) * | 1980-10-17 | 1988-08-23 | Pennwalt Corporation | 2-amino (or hydroxy) phenethyl-1,2,3,4-tetrahydroisoquinolines as analgesics |
| CN100509805C (zh) * | 2001-12-19 | 2009-07-08 | H.隆德贝克有限公司 | 3,4-二氢-1h-异喹啉-2-基-衍生物 |
| WO2005111025A1 (en) * | 2004-04-29 | 2005-11-24 | Aventis Pharmaceuticals Inc. | 3-piperidinylisochroman-5-ols as dopamine agonists |
| RU2009136330A (ru) * | 2007-03-01 | 2011-04-10 | Янссен Фармацевтика Н.В. (Be) | Тетрагидроизохинолиновые соединения в качестве модуляторов гистаминового н3 рецептора |
-
2015
- 2015-10-06 BR BR112017007123-1A patent/BR112017007123B1/pt not_active IP Right Cessation
- 2015-10-06 ES ES15775688T patent/ES2821821T3/es active Active
- 2015-10-06 WO PCT/EP2015/073053 patent/WO2016055479A1/en not_active Ceased
- 2015-10-06 CN CN201580064005.3A patent/CN107001278B/zh not_active Expired - Fee Related
- 2015-10-06 DK DK15775688.3T patent/DK3204359T3/da active
- 2015-10-06 SI SI201531348T patent/SI3204359T1/sl unknown
- 2015-10-06 LT LTEP15775688.3T patent/LT3204359T/lt unknown
- 2015-10-06 US US15/517,795 patent/US10105359B2/en active Active
- 2015-10-06 RS RS20201139A patent/RS60933B1/sr unknown
- 2015-10-06 PT PT157756883T patent/PT3204359T/pt unknown
- 2015-10-06 JP JP2017518989A patent/JP6622299B2/ja active Active
- 2015-10-06 HU HUE15775688A patent/HUE050664T2/hu unknown
- 2015-10-06 EP EP15775688.3A patent/EP3204359B1/en active Active
- 2015-10-06 CA CA2963951A patent/CA2963951C/en active Active
- 2015-10-06 PL PL15775688.3T patent/PL3204359T3/pl unknown
- 2015-10-06 EA EA201790785A patent/EA035544B1/ru not_active IP Right Cessation
- 2015-10-06 HR HRP20201469TT patent/HRP20201469T1/hr unknown
-
2020
- 2020-09-30 CY CY20201100923T patent/CY1123417T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| LT3204359T (lt) | 2020-10-12 |
| DK3204359T3 (da) | 2020-09-14 |
| EP3204359A1 (en) | 2017-08-16 |
| RS60933B1 (sr) | 2020-11-30 |
| HUE050664T2 (hu) | 2020-12-28 |
| CA2963951A1 (en) | 2016-04-14 |
| BR112017007123B1 (pt) | 2023-01-31 |
| PL3204359T3 (pl) | 2021-03-22 |
| CN107001278B (zh) | 2020-11-24 |
| US20170304292A1 (en) | 2017-10-26 |
| EA201790785A1 (ru) | 2017-10-31 |
| US10105359B2 (en) | 2018-10-23 |
| ES2821821T3 (es) | 2021-04-27 |
| EA035544B1 (ru) | 2020-07-03 |
| JP2017530185A (ja) | 2017-10-12 |
| CA2963951C (en) | 2023-02-28 |
| EP3204359B1 (en) | 2020-07-01 |
| JP6622299B2 (ja) | 2019-12-18 |
| PT3204359T (pt) | 2020-09-24 |
| HRP20201469T1 (hr) | 2020-12-11 |
| WO2016055479A1 (en) | 2016-04-14 |
| CN107001278A (zh) | 2017-08-01 |
| BR112017007123A2 (pt) | 2017-12-19 |
| CY1123417T1 (el) | 2021-12-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT3204359T (pt) | Derivados de tetra-hidroisoquinolinas | |
| AU361515S (en) | Dishrack | |
| AU362944S (en) | Lapboard | |
| IL253381B (en) | History of h9–pyrrolo–dipyridine | |
| SG11201609205WA (en) | Heterocyclyl-butanamide derivatives | |
| PL3418273T3 (pl) | Pochodne flawaglin | |
| PL3233890T3 (pl) | Pestiwirus | |
| HUE050450T2 (hu) | Fluoralkil-fluorén-származékok | |
| IL248773A0 (en) | History of naphthyridinedione | |
| IL261055A (en) | Derivatives of tetrahydroisoquinoline | |
| IL251005B (en) | Pyrido-oxazinone derivatives | |
| SG11201608634RA (en) | Cycloalkyl-linked diheterocycle derivatives | |
| HUE044703T2 (hu) | Új CYP-eikozanoid származékok | |
| PL3119744T3 (pl) | Pochodne 2-cyjano-3-cyklopropylo-3-hydroksy-N-arylo-tioakryloamidu | |
| GB2530305B (en) | Tracers | |
| GB201707862D0 (en) | Tracers | |
| GB201418365D0 (en) | Tracers | |
| GB201409664D0 (en) | Tracers | |
| AU5285P (en) | FLOMANRER Mandevilla sanderi | |
| AU5287P (en) | FLOMANPIW Mandevilla sanderi | |
| AU5289P (en) | FLOMANFOP Mandevilla sanderi | |
| AU5288P (en) | FLOMANTOG Mandevilla sanderi | |
| AU5286P (en) | FLOMANWHW Mandevilla sanderi | |
| AU2014264V (en) | FlatGL Templetonia retusa | |
| GB201407585D0 (en) | SMA-Inter Act |